Angel Yeast announced that its wholly-owned subsidiary Enzyme Formulation Company plans to invest 370 million yuan to build a new synthetic biology pilot verification base project. The main content of the project is to build a new extraction workshop and fermentation plant. The construction period is expected to be 16 months, and the estimated start time is March 2027. The project is funded by the company itself, and the return on investment is expected to be 9.79%. The project has been reviewed and approved by the company's board of directors, and still needs to be submitted to the shareholders' meeting for review and approval by relevant departments. The implementation of the project will help enhance the company's core competitiveness in the field of biological manufacturing.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.